Erik Miller
Internal Medicine · Warsaw, MONPI 1235131723
Payments from drug & device makers
Across 54 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$178
- Merck$109
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$75
- Pfizer$70
- AstraZeneca$70
- Sunovion Pharmaceuticals Inc.$56
- plus $342 from 15 others
What the payments were for
- Food & beverage$900100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $178 |
| Merck | 7 | $109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $75 |
| Pfizer | 5 | $70 |
| AstraZeneca | 5 | $70 |
| Sunovion Pharmaceuticals Inc. | 3 | $56 |
| Novartis | 3 | $53 |
| Novo Nordisk | 2 | $35 |
| Bayer | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Abbott | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Amgen | 1 | $13 |
| Exact Sciences | 1 | $13 |
How this compares
$900 in reported general payments places this provider in the 70th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 179 | $182,616 |
| FarxigaDapagliflozin Propanediol | 198 | $169,486 |
| TrulicityDulaglutide | 77 | $92,631 |
| JardianceEmpagliflozin | 97 | $84,203 |
| EliquisApixaban | 81 | $59,814 |
| XareltoRivaroxaban | 64 | $57,223 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $55,690 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 53 | $40,719 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 67 | $40,602 |
| MounjaroTirzepatide | 33 | $35,208 |
| Spiriva RespimatTiotropium Bromide | 41 | $27,848 |
| VraylarCariprazine Hcl | 16 | $24,102 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $20,498 |
| ByettaExenatide | 20 | $18,899 |
| TradjentaLinagliptin | 27 | $18,780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Byetta, Bevespi Aerosphere | $70 | $239,161293 claims |
| Novo NordiskOzempic | $35 | $182,616179 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat, Tradjenta, Combivent Respimat | $16 | $176,804243 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $16 | $127,838110 claims |
| PfizerEliquis | $70 | $59,81481 claims |
| AbbVieVraylar | $178 | $24,10216 claims |
| MerckBelsomra | $109 | $18,54645 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $14 | $11,64913 claims |
| NovartisEntresto | $53 | $8,31812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Warsaw
- Timothy SmithSaint Peters$21.4M
- Craig DietzKansas City$4M
- Michael ReschakSaint Louis$3.1M
- Dima DandachiColumbia$1.2M
- Santosh SharmaKansas City$782K
- Jianbo WangChesterfield$643K
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
- Dubert GuerreroIndependence$369K
- Hany SalamaSaint Louis$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.